13.77

4.38% -0.63

After Hours: 13.69 -0.08 -0.58%

Conexeu Sciences Inc (CNXU)

Overview News Price History Discussions Forecast

Conexeu Sciences Inc stock is traded at $13.77, with a volume of 45,080. It is down -4.38% in the last 24 hours and up +0.00% over the past month. Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Previous Close:

$14.40

Open:

$14.7

24h Volume:

45,080

Relative Volume:

38.71

Market Cap:

$288.02M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+0.00%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$13.00

$15.64

1-Week Range:

$12.72

$15.64

52-Week Range:

$12.72

$15.64

Conexeu Sciences Inc Stock (CNXU) Company Profile

Name

Conexeu Sciences Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

CNXU's Discussions on Twitter

Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNXU Conexeu Sciences Inc	13.77	301.19M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Conexeu Sciences Inc Stock (CNXU) Latest News

04:42 AM

Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat

04:42 AM

03:06 AM

Conexeu Sciences (CNXU) Stock Chart and Price History 2026 - MarketBeat

03:06 AM

May 25, 2026

Conexeu Sciences (CNXU) Stock Analysis Report | Financials & Insights - Benzinga

May 25, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 25, 2026

May 24, 2026

Total debt of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView

May 24, 2026

May 23, 2026

CNXU Price Today: Conexeu Sciences Inc. Stock Price, Quote & Chart | MEXC - MEXC

May 23, 2026

Conexeu Sciences (CNXU) Stock Price, News & Analysis - MarketBeat

May 23, 2026

Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat

May 23, 2026

U.S. IPO Weekly Recap: SpaceX Files Papers For What Could Be The Largest IPO In History - Seeking Alpha

May 23, 2026

May 22, 2026

CNXU Technical Analysis | Trend, Signals & Chart Patterns | Conexeu Sciences Inc (NASDAQ:CNXU) - ChartMill

May 22, 2026

Conexeu Sciences debuts on Nasdaq with a unique regenerative tissue platform targeting multiple markets. - Pluang

May 22, 2026

CNXU Stock Price, Quote & Chart | Conexeu Sciences Inc (NASDAQ:CNXU) - ChartMill

May 22, 2026

CNXU Forecast — Price Prediction for 2026. Should I Buy CNXU? - Intellectia AI

May 22, 2026

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself - The Manila Times

May 22, 2026

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It - PR Newswire

May 22, 2026

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire

May 22, 2026

May 21, 2026